These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2541089)

  • 1. Imipramine binding sites in brain and platelets: role in affective disorders.
    Hrdina PD
    Int J Clin Pharmacol Res; 1989; 9(2):119-22. PubMed ID: 2541089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity 3H-imipramine binding: a new biological marker in depression.
    Langer SZ; Zarifian E; Briley M; Raisman R; Sechter D
    Pharmacopsychiatria; 1982 Jan; 15(1):4-10. PubMed ID: 7038720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site.
    Langer SZ; Lee CR; Schoemaker H; Segonzac A; Esnaud H
    Prog Clin Biol Res; 1985; 192():441-55. PubMed ID: 3001765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
    Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
    Dumbrille-Ross A; Tang SW
    Mol Pharmacol; 1983 May; 23(3):607-13. PubMed ID: 6306430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of imipramine and trazodone on the re-uptake of (3H) serotonin by thrombocytes in patients with endogenous depression: changes in antidepressive therapy].
    Katasonow AB; Brusow OS; Beljaew BS; Slobina GP; Faktor MI; Larionowa TB; Trunte K; Lidemann RR
    Psychiatr Neurol Med Psychol (Leipz); 1989 Apr; 41(4):210-7. PubMed ID: 2544916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
    Hrdina PD
    Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant binding: implications for the mode of action and the biology of depression.
    Hrdina PD
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):457-62. PubMed ID: 6320297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological issues in the preparation and assay of platelet 3H-imipramine binding.
    Severson JA; Schneider LS; Fredrickson ER
    Psychiatry Res; 1990 Jul; 33(1):19-29. PubMed ID: 1699244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of an imipramine endacoid in rat brain.
    Rehavi M; Ventura I; Sarne Y
    Prog Clin Biol Res; 1985; 192():465-72. PubMed ID: 3001767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
    Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
    J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High- and low-affinity [3H]imipramine binding sites on human platelets: separate determination and involvement of sulphur-containing bonds.
    Demushkin VP; Fomenko AM; Plyashkevich YG; Shchurin MR; Brusov OS
    Eur J Pharmacol; 1987 Aug; 140(2):171-8. PubMed ID: 2822438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of seasonal variation in platelet [3H]imipramine binding in humans.
    Galzin AM; Lôo H; Sechter D; Langer SZ
    Biol Psychiatry; 1986 Aug; 21(10):876-82. PubMed ID: 3017462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclasses of platelet 3H-imipramine binding sites.
    DeMet EM; Chicz-DeMet A
    Psychiatry Res; 1990 Dec; 34(3):293-302. PubMed ID: 1963692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet [3H]-imipramine binding according to DSM-III subtypes of depression.
    Jeanningros R; Gronier B; Azorin JM; Tissot R
    Neuropsychobiology; 1989; 22(1):33-40. PubMed ID: 2561683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of 3H-paroxetine-labeled serotonin uptake sites in rat brain].
    Yoshida Y
    Yakubutsu Seishin Kodo; 1988 Jun; 8(2):345-57. PubMed ID: 2975437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential 3H-imipramine platelet binding in patients with panic disorder and depression.
    Innis RB; Charney DS; Heninger GR
    Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity binding of 3H-imipramine in brain and platelets: relevance to depression and antidepressant drugs.
    Langer SZ; Sette M; Raisman R; Briley M
    Adv Biochem Psychopharmacol; 1982; 31():171-7. PubMed ID: 7044053
    [No Abstract]   [Full Text] [Related]  

  • 20. Labeling in vivo of serotonin uptake sites in rat brain after administration of [3H]cyanoimipramine.
    Wolfe J; Kreider MS; Goodman C; Brunswick DJ
    J Pharmacol Exp Ther; 1987 Apr; 241(1):196-203. PubMed ID: 3572782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.